Log In
Print this Print this

GemPac NanomAbs

  Manage Alerts
Collapse Summary General Information
Company Immune Pharmaceuticals Inc.
DescriptionAntibody nanoparticle conjugate
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationPancreatic cancer
Indication DetailsTreat pancreatic cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today